Effect of selective vaccination on a decrease in the rate of hepatitis B virus-positive Japanese first-time blood donors

Transfusion Medicine

Volumn 19, Issue 4, 2009, Pages 172-179

  Yoshikawa, A ^a   Suzuki, K ^b   Abe, A ^c   Tanaka, T ^b,e   Yamaguchi, K ^d   Ishikawa, Y ^b   Minegishi, K ^b   Gotanda, Y ^a   Yugi, H ^f   Uchida, S ^b   Satake, M ^f   Mizoguchi, H ^a   Tadokoro, K ^b  

^a Japanese Red Cross Society   (Japan)

^b Japanese Red Cross Headquarters   (Japan)

^c ADVANCED TELECOMMUNICATIONS RESEARCH INSTITUTE INTERNATIONAL   (Japan)

^d HITOTSUBASHI UNIVERSITY   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f 3256 Midori cho   (Japan)

Author keywords

First time blood donors; HBV selective vaccination; Principal component analysis; Regression analysis

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BIRTH; BLOOD DONOR; BLOOD SAMPLING; DRUG EFFECT; DRUG EFFICACY; FEMALE; GOVERNMENT; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRINCIPAL COMPONENT ANALYSIS; RED CROSS; SEROLOGY; TRANSFUSION; VACCINATION; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; BLOOD DONORS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; JAPAN; MALE; RED CROSS; RETROSPECTIVE STUDIES; VACCINATION;

EID: 69249166593     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2009.00930.x     Document Type: Article

References (26)

1. Chiyoda, S., Oda, H., Kotani, T., Kusuba, E. & Kusano, T. (2006) The effect of a nationwide prevention program for mother-to-infant infection by HBV evaluated by viral markers in blood donors in Nagasaki prefecture. Japan Journal of Transfusion Medicine, 52, 52 56.
2. Gervais, A., Longuet, P. & Leport, C. (2008) A success story: universal vaccination in Italy-what has to be done to eradicate residual acute hepatitis B? Clinical Infectious Diseases, 46, 876 877.
3. Hanè, S., Ramsay, M., Balogun, K., Edmunds, W.J. & Mortimer, P. (2004) Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunization policy. Journal of Clinical Virology, 29, 211 220.
4. Hayashi, K., Katano, Y., Takeda, Y. et al. (2007) Comparison of hepatitis B virus subgenotypes inpatients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan. Journal of Medical Virology, 79, 366 373.
5. Hens, N., Aerts, M., Shkedy, Z., Kung'ukimani, P., Kojouhorova, M., Vandamme, P. & Beutels, Ph. (2008) Estimating the impact of vaccination using age-time-dependent incidence rates of hepatitis B. Epidemiology and Infection, 136, 341 351.
6. Iizuka, H., Ohmura, K., Ishijima, A. et al. (1992) Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sanguinis, 63, 107 111.
7. Inui, A., Komatsu, H., Sogo, T., Nagai, T., Abe, K. & Fujisawa, T. (2007) Hepatitis B virus genotypes in children and adolescents in Japan: before and after immunization for the prevention of mother to infant transmission of hepatitis B virus. Journal of Medical Virology, 79, 670 675.
8. Koibuchi, T., Hitani, A., Nakamura, T., Nojiri, N., Nakajima, K., Jyuji, T. & Iwamoto, A. (2001) Predominance of genotype A HBV in an HBV-HIV-1 dually positive population compared with an HIV-1-negative counterpart in Japan. Journal of Medical Virology, 64, 435 440.
9. Mele, A., Tosti, M.E., Mariano, A. et al. (2008) Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clinical Infectious Diseases, 46, 868 875.
10. Mikaeloff, Y., Caridade, G., Assi, S., Tardieu, M. & Suissa, S. (2007) Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain, 130, 1105 1110.
11. Mine, H., Emura, H., Miyamoto, M. et al. (2003) High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. Journal of Virological Methods, 112, 145 151.
12. Murokawa, H., Yoshikawa, A., Ohnuma, H. et al. (2005) Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sanguinis, 88, 10 16.
13. Ni, Y.H., Huang, L.M., Chang, M.H. et al. (2007) Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology, 132, 1287 1293.
14. O'Brien, S.F., Fan, W., Xi, G. et al. (2008) Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies. Transfusion, 48, 902 909.
15. Ohnuma, H., Yoshikawa, A., Mizoguchi, H. & Okamoto, H. (2005) Characterization of genotype H hepatitis B virus strain identified for the first time from a Japanese blood donor by nucleic acid amplification test. The Journal of General Virology, 86, 595 599.
16. Orito, E., Ichida, T., Sakugawa, H. et al. (2001) Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology, 34, 590 594.
17. Ringwald, J., Mertz, I., Zimmermann, R. et al. (2005) Hepatitis B virus vaccination of blood donors-what costs may be expected? Transfusion Medicine, 15, 83 92.
18. Shiraki, K. (1994) Vertical transmission of hepatitis B virus and its prevention in Japan. In: Viral Hepatitis and Liver Disease (eds Nishioka, K., Suzuki, H., Mishiro, S. & Oda, T. 530 532. Spring-Verlag, Tokyo.
19. Shiraki, K., Nagata, I., Iizuka, T. & Kaji, S. (1996) Mother-to-infant infection by hepatitis B virus and its prevention in Japan. International Hepatology Communications, 5, 74 78.
20. Su, F.H., Chen, J.D., Cheng, S.H., Sung, K.Y., Jeng, J.J. & Chu, F.Y. (2008) Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme. Journal of Viral Hepatitis, 15, 14 19.
21. Sugauchi, F., Orito, E., Ohno, T. et al. (2006) Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. Hepatology Research, 36, 107 114.
22. Takeda, Y., Katano, Y., Hayashi, K. et al. (2006) Difference of HBV genotype distribution between acute hepatitis and chronic hepatitis in Japan. Infection, 34, 201 207.
23. Tanaka, J., Kumagai, J., Katayama, K. et al. (2004) Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000. Intervirology, 47, 32 40.
24. Uchida, S. & Tadokoro, K. (2008) Positive rate of hepatitis B surface antigen in 16-year-old first-time blood donors: effectiveness of immunoprophylaxis with hepatitis B vaccine and immunoglobulin in newborn infants with mothers positive for hepatitis B e antigen. Japanese Journal of Infectious Diseases, 61, 94.
25. World Health Organization 1992) Expanded programme on immunization global advisory group. Weekly Epidemiological Record, 3, 11 16.
26. Yugi, H., Mizui, M., Tanaka, J. & Yoshizawa, H. (2006) Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing-Japanese experience. Journal of Clinical Virology, 36, S56 S64.